Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 38151 - 38175 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	PLCH1	23007	downregulated	entinostat results in decreased expression of PLCH1 mRNA	3q25.31	A21037
Entinostat	Investigational	PLD1	5337	upregulated	entinostat results in increased expression of PLD1 mRNA	3q26.31	A21035
Entinostat	Investigational	PLD5	200150	downregulated	entinostat results in decreased expression of PLD5 mRNA	1q43	A21037
Entinostat	Investigational	PLEKHA2	59339	upregulated	entinostat results in increased expression of PLEKHA2 mRNA	8p11.22	A21037
Entinostat	Investigational	PLEKHA3	65977	downregulated	entinostat results in decreased expression of PLEKHA3 mRNA	2q31.2	A21037
Entinostat	Investigational	PLEKHA4	57664	upregulated	entinostat results in increased expression of PLEKHA4 mRNA	19q13.33	A21035
Entinostat	Investigational	PLEKHB1	58473	upregulated	entinostat results in increased expression of PLEKHB1 mRNA	11q13.4	A21035
Entinostat	Investigational	PLEKHG1	57480	downregulated	entinostat results in decreased expression of PLEKHG1 mRNA	6q25.1	A21037
Entinostat	Investigational	PLEKHG3	26030	upregulated	entinostat results in increased expression of PLEKHG3 mRNA	14q23.3	A21035
Entinostat	Investigational	PLEKHG4	25894	upregulated	entinostat results in increased expression of PLEKHG4 mRNA	16q22.1	A21035
Entinostat	Investigational	PLEKHH2	130271	upregulated	entinostat results in increased expression of PLEKHH2 mRNA	2p21	A21035
Entinostat	Investigational	PLEKHM3	389072	downregulated	entinostat results in decreased expression of PLEKHM3 mRNA	2q33.3	A21037
Entinostat	Investigational	PLG	5340	downregulated	entinostat results in decreased expression of PLG mRNA	6q26	A21035
Entinostat	Investigational	PLLP	51090	upregulated	entinostat results in increased expression of PLLP mRNA	16q13	A21035
Entinostat	Investigational	PLOD2	5352	upregulated	entinostat results in increased expression of PLOD2 mRNA	3q24	A21037
Entinostat	Investigational	PLP2	5355	upregulated	entinostat results in increased expression of PLP2 mRNA	Xp11.23	A21037 A21035
Entinostat	Investigational	PLPP2	8612	upregulated	entinostat results in increased expression of PLPP2 mRNA	19p13.3	A21037 A21035
Entinostat	Investigational	PLPP3	8613	upregulated	entinostat results in increased expression of PLPP3 mRNA	1p32.2	A21035
Entinostat	Investigational	PLPP4	196051	downregulated	entinostat results in decreased expression of PLPP4 mRNA	10q26.12	A21037
Entinostat	Investigational	PLPP5	84513	downregulated	entinostat results in decreased expression of PLPP5 mRNA	8p11.23	A21035
Entinostat	Investigational	PLPPR5	163404	upregulated	entinostat results in increased expression of PLPPR5 mRNA	1p21.3	A21037
Entinostat	Investigational	PLS1	5357	upregulated	entinostat results in increased expression of PLS1 mRNA	3q23	A21037
Entinostat	Investigational	PLS3	5358	upregulated	entinostat results in increased expression of PLS3 mRNA	Xq23	A21037
Entinostat	Investigational	PLSCR1	5359	upregulated	entinostat results in increased expression of PLSCR1 mRNA	3q24	A21037
Entinostat	Investigational	PLTP	5360	upregulated	entinostat results in increased expression of PLTP mRNA	20q13.12	A21037

Displaying entries 38151 - 38175 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability